Oculentis wins STEP Award 2012

December 7, 2012

Article

Oculentis was awarded the STEP Award in the 'Market/Customer' category for 2012.

Oculentis was awarded the STEP Award in the 'Market/Customer' category for 2012.

The company received the prize, along with a €10 000 endowment, for it's strong customer focus on the manufacturer of intraocular lenses. This includes the multifocal lens LENTIS Mplus and the multifocal toric lens LENTIS Mplus toric.

Oculentis has successfully placed their products on the international market, meaning patients have access to refractive vision impairment with improved quality of life and better vision.

The STEP Award is given to innovative and high growth companies located in Germany, Austria and Switzerland. Further details can be found at www.step-award.de.

Recent Videos

Patrick C. Staropoli, MD, discusses clinical characterisation of Hexokinase 1 (HK1) mutations causing autosomal dominant pericentral retinitis pigmentosa

Richard B. Rosen, MD, discusses his ASRS presentation on illuminating subclinical sickle cell activities using dynamic OCT angiography

ASRS 2024: Socioeconomic barriers and visual outcomes in patients with rhegmatogenous retinal detachments, from Sally S. Ong, MD

Ashkan Abbey, MD, speaks about his presentation on the the CALM registry study, the 36-month outcomes of real world patients receiving fluocinolone acetonide 0.18 mg at the annual ASRS meeting in Stockholm, Sweden.

Nikoloz Labauri, MD, FVRS, speaks at the 2024 ASRS meeting about suspensory macular buckling as a novel technique for addressing myopic traction maculopathy

Jordana Fein, MD, MS, speaks with Modern Retina about the IOP outcomes with aflibercept 8 mg and 2 mg in patients with DME through week 48 of the phase 2/3 PHOTON trial at the annual ASRS meeting in Stockholm, Sweden.

John T. Thompson, MD, discusses his presentation at ASRS, Long-Term Results of Macular Hole Surgery With Long-Acting Gas Tamponade and Internal Limiting Membrane Peeling

ASRS 2024: Michael Singer, MD, shares 100-week results from the RESTORE trial

Related Content

A woman stands at a lectern delivering a presentation to an audience. She is viewed through the blur of the crowded audience. Image credit: ©as-artmedia – stock.adobe.com

Industry preview: Eye care companies announce presentations ahead of ASRS meeting

Companies in the retina space announced presentations ahead of the American Society of Retina Specialists meeting, to be held 17-20 July

A person with alopecia areata examines their scalp. Image credit: ©Nadya Kolobova – stock.adobe.com

Alopecia areata and underlying corneal pathologies

Investigators conducted a case-control study to investigate the corneal topography parameters and biomechanics in patients with alopecia areata

An architectural impression of the Oriel eye health centre exterior. Rendering courtesy Moorfields Eye Charity.

Impact report highlights outcomes of Moorfields Eye Charity programmes

The organisation has secured £72.75 million for its new eye health centre

Arrows hit a target on a yellow background. Image credit: ©MclittleStock – stock.adobe.com

VEGF-C and VEGF-D signaling pathways: Potential targets for treating wet AMD

A novel formulation may prevent blood vessel growth and vascular leakage in the retina

A 2mg branded Ozempic injector. Image credit: ©Fernanda – stock.adobe.com

Semaglutide may be associated with non-arteritic ischemic optic neuropathy (NAION)

GLP-1 receptor agonists, such as Wegovy, Ozempic and Novo Nordisk, are becoming more prolific

A scientist in a laboratory puts samples into a petri dish. Image credit: ©RFBSIP – stock.adobe.com

Beacon Therapeutics announces new board members, funding to support XLRP and AMD programmes

Martin David Harp

The company has secured $170 million (approximately €157 million) in Series B funding

Related Content

A woman stands at a lectern delivering a presentation to an audience. She is viewed through the blur of the crowded audience. Image credit: ©as-artmedia – stock.adobe.com

Industry preview: Eye care companies announce presentations ahead of ASRS meeting

Companies in the retina space announced presentations ahead of the American Society of Retina Specialists meeting, to be held 17-20 July

A person with alopecia areata examines their scalp. Image credit: ©Nadya Kolobova – stock.adobe.com

Alopecia areata and underlying corneal pathologies

Investigators conducted a case-control study to investigate the corneal topography parameters and biomechanics in patients with alopecia areata

An architectural impression of the Oriel eye health centre exterior. Rendering courtesy Moorfields Eye Charity.

Impact report highlights outcomes of Moorfields Eye Charity programmes

The organisation has secured £72.75 million for its new eye health centre

Arrows hit a target on a yellow background. Image credit: ©MclittleStock – stock.adobe.com

VEGF-C and VEGF-D signaling pathways: Potential targets for treating wet AMD

A novel formulation may prevent blood vessel growth and vascular leakage in the retina

A 2mg branded Ozempic injector. Image credit: ©Fernanda – stock.adobe.com

Semaglutide may be associated with non-arteritic ischemic optic neuropathy (NAION)

GLP-1 receptor agonists, such as Wegovy, Ozempic and Novo Nordisk, are becoming more prolific

A scientist in a laboratory puts samples into a petri dish. Image credit: ©RFBSIP – stock.adobe.com

Beacon Therapeutics announces new board members, funding to support XLRP and AMD programmes

Martin David Harp

The company has secured $170 million (approximately €157 million) in Series B funding

Terms and Conditions

Do Not Sell My Personal Information

Contact Info

2 Commerce Drive
Cranbury, NJ 08512

© 2024 MJH Life Sciences

All rights reserved.